← Leaderboards
Simina Maria Boca
Georgetown University
$497,401
Attributed
$497,401
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $245.3K · FY2017–19$250K$187.5K$125K$62.5K$0
'17
'18
'19
Funding mix
By agency
NIH$497,401 · 1
By mechanism
R21$497,401 · 1
Top collaborators
No co-investigators on record.
Most similar at Georgetown University
Same institution · by research overlap
- Arnold L Potosky$11,589,176
- Martin Morad$8,734,154
- Joyce Marie Slingerland$12,812,016
- Jeanine M. Genkinger$8,629,090
- Subha Madhavan$8,516,654
Others in their field
Other Emerging Leaders on “Affect”
- Chanza Baytop · Westat, Inc.$271,217,917
- Leonard Freedman · Leidos Biomedical Research, Inc.$62,378,387
- Jennifer Marie Suga · Kaiser Foundation Research Institute$29,218,159
- Lynn Briscoe · Leidos Biomedical Research, Inc.$27,788,199
- George Robert Painter · University Of Alabama At Birmingham$27,619,145
- Jessica Brooke Langbaum · Banner Health$22,633,312
Research focus
AffectActionable MutationAnticancer ResearchBaseAnalytical ToolBiometryCancer Cell LineCancer PatientCancer TypeClinical Decision-MakingBiological MarkersClinical ResearchCommunitiesComputer FrameworkComputer ScienceComputer SoftwareData AnalysesData ManagementData SetData VisualizationDesignEvidence BaseFailureFair Principles
Grant awards (4)
CGDnet: Cancer Gene Drug Network: Using patient-specific drug-gene networks for recommending targeted cancer therapies.$36,728
R21 · FY2019 · CA · contact PI
CGDnet: Cancer Gene Drug Network: Using patient-specific drug-gene networks for recommending targeted cancer therapies.$167,587
R21 · FY2018 · CA · contact PI
Integration of 3D primary tumor drug-profiling with patient-specific drug gene networks for recommending targeted cancer therapies (2 of 2).$77,750
R21 · FY2018 · CA · contact PI
CGDnet: Cancer Gene Drug Network: Using patient-specific drug-gene networks for recommending targeted cancer therapies.$215,336
R21 · FY2017 · CA · contact PI